Join our doctors as they unravel the mysteries behind Ozempic, an drug that has recently gained in popularity in the weight loss world. Semaglutide, the generic name for Ozempic, is a GLP agonist initially developed for the treatment of diabetes and obesity. However, its remarkable ability to regulate appetite and glucose levels has propelled it into the spotlight as a potent weight loss aid. In this episode, the doctors explore the health benefits of the drugs as well as the potential side effects and downsides. Finally the doctors weigh in on their professional opinions about the drug, including their insight into its longterm implications on longevity and overall health optimization. Join the Wild Health podcast as they unravel the science, facts, and latest research behind Ozempic and semaglutide. References: SUSTAIN Trial - https://www.nejm.org/doi/full/10.1056/nejmoa1607141 STEP Trial - https://www.nejm.org/doi/full/10.1056/NEJMoa2032183 SURPASS2 Trial - https://www.nejm.org/doi/full/10.1056/NEJMoa2107519

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related